Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +36.87%
#3 Fabric Protocol Fabric Protocol +18.73%
#4 Cysic Cysic +17.50%
#5 Bedrock Bedrock +10.70%
#6 Cap Cap +8.99%
#7 stake.link stake.link +6.45%
#8 Pons Pons +5.85%
#9 Enso Enso +5.58%
#10 Perle Perle +5.03%
Coin of the day
EXOD EXOD
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Pascal Biosciences Inc. Pascal Biosciences Inc.

Pascal Biosciences Inc.

PSCBF
Classifica tra le azioni #37975
Pascal Biosciences Inc. is an innovative biopharmaceutical firm dedicated to... Pascal Biosciences Inc. is an innovative biopharmaceutical firm dedicated to discovering and advancing therapeutic solutions for oncology and bolstering immune system function. The company's robust pipeline includes several key candidates: PAS-403, a potent mitosis inhibitor designed to impede cancerous cell division, specifically targeting glioblastoma and secondary brain tumors; and PAS-393, an immunomodulatory cannabinoid developed to enhance the immune system's recognition of tumor cells when utilized alongside checkpoint inhibitor therapy. Furthermore, Pascal is progressing a specialized antibody therapy aimed at B-cells, intended for conditions like acute lymphoblastic leukemia and various B-cell lymphomas. The company is also investigating cannabinoid-derived products as potential treatments for COVID-19. To support its research, Pascal Biosciences maintains an exclusive licensing agreement with the University of Washington for a cannabinoid-based therapeutic against glioblastoma multiforme and brain metastases. It also benefits from a collaborative research partnership with SoRSE Technology Corporation, focused on advancing PAS-393 toward clinical trials. Founded in 2011, the company operates from its headquarters in Seattle, Washington.
Prezzo delle azioni
$0.1
Ultima sincronizzazione: 2024-06-18
Capitalizzazione di mercato
$1.31M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia Pascal Biosciences Inc. (PSCBF)

Categoria

Healthcare
Margine operativo per Pascal Biosciences Inc. (PSCBF)
Margine operativo al August 2026 TTM: -133.68%
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Pascal Biosciences Inc., il margine operativo attuale (TTM) è -133.68%. Alla fine del 2022, il margine operativo era 0.00%.
Storico del margine operativo per Pascal Biosciences Inc. da 2019 a 2026
Margine operativo alla fine di ogni anno
Anno Margine Operativo Cambia
2026 (TTM) -133.68% 0.00%
2023 -133.68% 0.00%
2022 0.00% 0.00%
2021 0.00% 0.00%
2020 0.00% 0.00%
2019 0.00% 0.00%
Margine operativo per aziende simili o concorrenti
Azienda Margine Operativo Differenza del margine operativo Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
38.97% -100.29%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
28.81% -100.22%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00% -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
0.00% -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
31.23% -100.23%
BE
Cos'è l'Margine operativo di un'azienda?
L'Margine operativo è un indicatore chiave per valutare la redditività di un'azienda. Margini operativi più elevati sono generalmente preferibili poiché indicano che l'azienda riesce a vendere i propri prodotti o servizi a un prezzo significativamente superiore rispetto ai costi di produzione. Si calcola dividendo gli utili per i ricavi.